PAUSHAKLTD

Paushak Limited

Specialty chemicals manufacturer of Alembic group

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

paushak.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹826.35
Market cap
2,038 Cr
Stock P/E
43.1
P/B
3.94
Dividend yield
0.3%
ROE (FY26)
8.0%
ROCE (FY26)
9.1%
Operating margin (FY26)
18.0%
Debt / equity (FY26)
0.16
OCF / EBITDA (FY26)
88.2%
OCF / EBITDA (3Y)
79.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Paushak makes specialty chemicals using phosgene-based chemistry, mainly for pharmaceutical, agrochemical, performance chemical and custom synthesis customers, and is part of the Alembic group.

Company snapshot

36thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Net margin of 18.0% — the business keeps a healthy share of every rupee it earns.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Sales52 Cr54 Cr52 Cr57 Cr49 Cr52 Cr56 Cr59 Cr49 Cr55 Cr84 Cr89 Cr
Operating expenses (approx.)33 Cr35 Cr40 Cr40 Cr35 Cr36 Cr38 Cr44 Cr37 Cr38 Cr58 Cr63 Cr
EBITDA19 Cr19 Cr12 Cr17 Cr15 Cr16 Cr18 Cr15 Cr11 Cr17 Cr26 Cr26 Cr
OPM %36.3%35.3%23.2%29.7%29.8%30.3%31.9%25.2%23.4%30.3%30.7%29.5%
Other income3 Cr7 Cr4 Cr4 Cr6 Cr0.11 Cr2 Cr1 Cr0.97 Cr8 Cr3 Cr2 Cr
Interest0.02 Cr0.01 Cr0.03 Cr0.03 Cr0.03 Cr0.06 Cr0.04 Cr0.04 Cr0.01 Cr1 Cr1 Cr1 Cr
Depreciation3 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr5 Cr8 Cr8 Cr8 Cr
Profit before tax18 Cr23 Cr12 Cr17 Cr17 Cr12 Cr16 Cr11 Cr7 Cr16 Cr19 Cr19 Cr
Tax %25.8%18.9%17.2%15.9%11.3%21.5%23.0%24.0%16.9%21.9%20.6%27.3%
Net profit14 Cr18 Cr10 Cr14 Cr15 Cr10 Cr12 Cr9 Cr6 Cr13 Cr15 Cr14 Cr
EPS (₹)₹44.21₹59.23₹33.44₹46.09₹49.51₹31.16₹39.04₹27.94₹2.50₹5.07₹6.13₹5.48

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales72 Cr105 Cr140 Cr138 Cr141 Cr150 Cr212 Cr206 Cr211 Cr219 CrSign in free for the trailing twelve months
Operating expenses (approx.)60 Cr76 Cr99 Cr95 Cr91 Cr96 Cr137 Cr142 Cr151 Cr158 CrSign in free for the trailing twelve months
EBITDA12 Cr29 Cr40 Cr43 Cr50 Cr54 Cr75 Cr64 Cr60 Cr61 CrSign in free for the trailing twelve months
OPM %17.0%27.9%28.8%31.0%35.8%36.1%35.4%31.3%28.3%27.8%Sign in free for the trailing twelve months
Other income5 Cr3 Cr3 Cr5 Cr6 Cr5 Cr9 Cr20 Cr14 Cr12 CrSign in free for the trailing twelve months
Interest0.06 Cr0.10 Cr0.14 Cr0.08 Cr0.05 Cr0.06 Cr0.31 Cr0.15 Cr0.14 Cr1 CrSign in free for the trailing twelve months
Depreciation3 Cr3 Cr4 Cr4 Cr5 Cr9 Cr13 Cr14 Cr15 Cr21 CrSign in free for the trailing twelve months
Profit before tax14 Cr29 Cr49 Cr45 Cr52 Cr50 Cr72 Cr71 Cr59 Cr50 CrSign in free for the trailing twelve months
Tax %22.5%25.6%20.5%23.1%27.7%25.2%25.2%23.4%16.0%22.0%Sign in free for the trailing twelve months
Net profit11 Cr21 Cr39 Cr35 Cr37 Cr38 Cr54 Cr54 Cr49 Cr39 CrSign in free for the trailing twelve months
EPS (₹)₹34.12₹66.95₹125.64₹113.27₹121.02₹122.03₹175.22₹176.35₹160.21₹15.95Sign in free for the trailing twelve months
Dividend payout %————4.9%4.9%6.8%9.8%12.3%15.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr12 Cr
Reserves80 Cr110 Cr174 Cr224 Cr269 Cr302 Cr351 Cr405 Cr462 Cr479 Cr
Borrowings0.04 Cr0.57 Cr0.0035 Cr——0.12 Cr——25 Cr77 Cr
Other liabilities11 Cr31 Cr36 Cr43 Cr57 Cr61 Cr61 Cr73 Cr81 Cr92 Cr
Total liabilities94 Cr144 Cr214 Cr270 Cr329 Cr367 Cr415 Cr481 Cr572 Cr660 Cr
Fixed assets (net)35 Cr37 Cr38 Cr41 Cr51 Cr147 Cr149 Cr152 Cr141 Cr377 Cr
CWIP0.31 Cr0.98 Cr6 Cr16 Cr68 Cr8 Cr7 Cr29 Cr190 Cr26 Cr
Investments33 Cr53 Cr116 Cr163 Cr154 Cr151 Cr182 Cr223 Cr139 Cr150 Cr
Inventories9 Cr12 Cr18 Cr16 Cr14 Cr19 Cr23 Cr22 Cr22 Cr37 Cr
Trade receivables16 Cr39 Cr32 Cr26 Cr33 Cr40 Cr52 Cr51 Cr55 Cr55 Cr
Cash & bank0.03 Cr0.06 Cr0.54 Cr0.80 Cr0.18 Cr0.06 Cr0.52 Cr0.62 Cr0.01 Cr0.02 Cr
Other assets0.79 Cr3 Cr3 Cr7 Cr9 Cr2 Cr2 Cr4 Cr26 Cr16 Cr
Total assets94 Cr144 Cr214 Cr270 Cr329 Cr367 Cr415 Cr481 Cr572 Cr660 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity12 Cr10 Cr24 Cr41 Cr30 Cr44 Cr43 Cr56 Cr38 Cr54 Cr
Cash from investing-11 Cr-10 Cr-0.11 Cr-39 Cr-29 Cr-42 Cr-38 Cr-50 Cr-57 Cr-95 Cr
Cash from financing-2 Cr-0.60 Cr-23 Cr-2 Cr-2 Cr-2 Cr-4 Cr-5 Cr19 Cr42 Cr
Net cash flow-0.01 Cr0.06 Cr0.49 Cr0.27 Cr-0.62 Cr-0.12 Cr0.46 Cr0.10 Cr-0.61 Cr0.0041 Cr
Free cash flow (OCF − Capex)7 Cr5 Cr13 Cr24 Cr-26 Cr-4 Cr26 Cr17 Cr-123 Cr-34 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.1%25.5%27.7%20.0%19.0%16.5%20.5%17.4%12.0%9.1%
ROE %13.2%19.0%21.9%15.4%13.7%12.3%15.3%13.3%10.6%8.0%
Debtor days821358569859690909491
Inventory days130113110134171207172176181233
Days payable7216366113157202116129169195
Cash conversion cycle140851289099102146137107129
OCF / EBITDA %101.1%35.9%58.6%96.5%59.0%81.1%56.8%86.9%63.0%88.2%
OCF / EBITDA % (3 years)——56.9%67.1%70.9%78.0%64.7%73.6%68.4%79.6%
Debt / equity0.00040.00510.0000——0.0004——0.050.16
Current ratio3.692.515.996.813.493.836.608.302.242.01
Net debt / EBITDA0.00090.02-0.01-0.02-0.00360.0011-0.0069-0.00960.421.27